Isis Pharmaceuticals Inc.

Company Website

1896 Rutherford Road
Carlsbad, CA 92008

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Isis Pharmaceuticals Inc.

Market Cap as of 6/12/2015

$8,140,507,136

Market Cap as of 7/03/2014

$4,172,822,032

Market Cap as of 07/02/2013

$3,231,248,047

Market Cap as of 06/26/2012

$1,174,152,832

Market Cap as of 01/04/2012

$717,053,800

Market Cap as of 06/20/2011

$858,502,000

Market Cap as of 01/06/2011

$1,026,549,000

Exchange and Ticker Symbol

Nasdaq: ISIS

Fields of Research

Discovery and development of antisense drugs

Major Products

Drug pipeline comprises 26 drugs to primarily treat cardiovascular, metabolic, severe, and rare diseases, as well as cancer, including Kynamro, ISIS-SMNRx, LY2181308

View all the companies in San Diego Publicly Traded Companies

Isis Pharmaceuticals Inc.

Market Cap as of 6/12/2015

$8,140,507,136

Exchange

NASDAQ GS

Ticker

ISIS

Executives

Stanley Crooke (profile)

  • Chairman
  • Chief Executive Officer
  • Founder
  • President

Similar Companies

Biological Product (except Diagnostic) Manufacturing325414
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES2836